Pisgah Labs’ PSE Extraction-Resistance Work Undeterred By Claims Outlook
This article was originally published in The Tan Sheet
Executive Summary
Pisgah Labs patented a version of its P2P Interventions technology for pseudoephedrine extraction. But Pisgah and its competitors face a major challenge without an extraction-resistant claim approved by FDA.